A Study of Nilotinib Versus Imatinib in GIST Patients
Public ClinicalTrials.gov record NCT00785785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open Label, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).
Study identification
- NCT ID
- NCT00785785
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 644 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Oct 2014 (Actual)
- Completion
- Oct 2014 (Actual)
- Last update posted
- Jun 16, 2016
2009 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology Associates | Birmingham | Alabama | 35205 | — |
| Northern Arizona Hematology/Oncology Associates, P.C. Dept. of No. AZ Hem-Onc | Flagstaff | Arizona | 86001 | — |
| City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(4) | Duarte | California | 91010-3000 | — |
| City of Hope National Medical Center Regulatory Document | Duarte | California | 91010-3000 | — |
| University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (2) | La Jolla | California | 92093-0658 | — |
| University of California at Los Angeles GI Oncology Program | Los Angeles | California | 90095 | — |
| Stanford University Medical Center Stanford Cancer Center | Stanford | California | 94304 | — |
| University of Colorado Dept. of Univ. of Colorado | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer | Greenwood Village | Colorado | — | — |
| Washington Hospital Center Wash Hospital | Washington D.C. | District of Columbia | 20010 | — |
| Ocala Oncology Center Dept. of Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Kootenai Medical Center Dept.ofKootenai Med.Ctr. | Coeur d'Alene | Idaho | 83814 | — |
| Northwestern University Clinical Research Office (2) | Chicago | Illinois | 60611 | — |
| Dana Farber Cancer Institute Centerfor Sarcoma&BoneOncology | Boston | Massachusetts | 02215 | — |
| University of Michigan Comprehensive Cancer Center DeptofMichiganCancerCenter(6) | Ann Arbor | Michigan | 48109-0944 | — |
| Minnesota Oncology Hematology, P.A. SC | Minneapolis | Minnesota | 55404 | — |
| Mayo Clinic - Rochester Division of Hematology | Rochester | Minnesota | 55905 | — |
| New York Oncology Hematology, P.C. NYOH Amsterdam | Troy | New York | 12180 | — |
| New York Oncology Hematology, P.C. NYOH@AlbanyMedicalCenter(2) | Troy | New York | 12180 | — |
| University of Pennsylvania Medical Center CAMN107G2301 | Philadelphia | Pennsylvania | 19104-4283 | — |
| Vanderbilt Univeristy Ingram Cancer Ctr. | Nashville | Tennessee | 37232 | — |
| Texas Oncology, P.A. Tex Onc (2) | Bedford | Texas | 76022 | — |
| Texas Oncology Wichita Falls | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(3) | Dallas | Texas | 75390-8527 | — |
| University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) | Houston | Texas | 77030-4009 | — |
| Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) | San Antonio | Texas | 78229 | — |
| Tyler Cancer Center Dept.ofTylerCancerCtr. (2) | Tyler | Texas | 75702 | — |
| University of Utah / Huntsman Cancer Institute Dept.ofHuntsmanCancerInst.(3) | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00785785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2016 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00785785 live on ClinicalTrials.gov.